Roelandts 1994.
| Methods | multinational, multicentre, double blind, randomized, placebo controlled, parallel groups | |
| Participants | Senile dementia mild to moderate; 82 patients received nicergoline, 80 placebo; age > 55. | |
| Interventions | Nicergoline or Placebo 30mg. twice a day (os) for 6 months | |
| Outcomes | SCAG, GRS, MACC for efficacy; adverse events for safety | |
| Notes | ||